Equity Research, Broker Reports, and media content on Dechra Pharmaceuticals PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Dechra Pharmaceuticals PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Dechra Pharmaceuticals PLC

Company Profile

  • Personnel:
  • Ian Page, CEO
  • Tony Rice, Chairman

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Dechra Pharmaceuticals PLC. We currently have 267 research reports from 7 professional analysts.

  • Open: 3520p
  • Range Today: 3482/3532p
  • 52 Week: 3066/5525p
  • Daily Volume: 10.7k
  • Daily Liquidity: 0.01%
  • # Shares: 108.4m
  • Market Cap: £3,773m
  • Latest PE (hist): 94.69
  • Div Yield: 0.83
Date Source Announcement
30Jun22 12:09 RNS Dechra Pharmaceutcls - Total Voting Rights
13Jun22 10:33 RNS Dechra Pharmaceutcls - Director/PDMR Shareholding
17May22 11:04 RNS Dechra Pharmaceutcls - Appointment of John Shipsey as Non-Executive
03May22 09:49 RNS Dechra Pharmaceutcls - Total Voting Rights
19Apr22 07:00 RNS Dechra Pharmaceutcls - Holding(s) in Company
05Apr22 16:15 RNS Dechra Pharmaceutcls - Director/PDMR Shareholding
01Apr22 10:56 RNS Dechra Pharmaceutcls - Additional Listing
  • Frequency of research reports


  • Research reports on

    Dechra Pharmaceuticals PLC

  • Providers covering

    Dechra Pharmaceuticals PLC